p53 pathway dysfunction is highly prevalent in acute myeloid leukemia independent of TP53 mutational status
Crossref DOI link: https://doi.org/10.1038/leu.2016.350
Published Online: 2016-11-25
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Quintás-Cardama, A
Hu, C
Qutub, A
Qiu, Y H
Zhang, X
Post, S M
Zhang, N
Coombes, K
Kornblau, S M
Text and Data Mining valid from 2016-11-25
Version of Record valid from 2016-11-25
Article History
Received: 1 July 2016
Revised: 28 October 2016
Accepted: 2 November 2016
First Online: 25 November 2016